CDKN2A and neoplasm: In a previous study, we showed that hypermethylation of the p16INK4a gene promoter was present in 36% of mucosa samples obtained 10 cm from the tumor in patients with colorectal cancer.10 The presence of p16INK4a promoter methylation was associated with worse outcomes in the patients.